• Bio-Gate set a 5-for-1 share consolidation, combining five shares into one under a capital reduction plan.
• The consolidation process, including handling of fractional shares, remained incomplete as of July 20, 2026.
• Subscription rights for a planned rights issue were set at 5:1, or 25:1 based on pre-consolidation holdings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Gate AG published the original content used to generate this news brief on July 21, 2026, and is solely responsible for the information contained therein.